CDMO: Evolution of their role

CDMO: Evolution of their role

Innovative biopharmaceutical companies are increasingly engaging in strategic partnerships with CDMOs, whereas in the past, these companies relied more on transactional and fee-for-service relationships. 

SyrHA was able to see at CPHI Barcelona 2023 that the expectations of biopharmaceutical customers are increasing. 

All issues are concerned: the resolution of development and manufacturing challenges, the care given to quality, the respect of increasingly short deadlines and the rigor of delivery.

For their part, CDMOs are looking to expand their capabilities and enrich their services to support their customers from one end of the chain to the other.

Isn’t there a scattering of skills in this race to lengthen the list of services offered? A loss of identity and true value of CDMOs?

Could we see the emergence of CRDMOs, merging services provided by CROs, CDOs, CMOs and CPOs, which were historically fragmented?

Other CDMOs, such as SyrHA, prefer to play the expertise card: supporting their clients on a short list of subjects but in a totally controlled way. Leaving the issues of regulatory registration and packaging to the service providers whose job it is.

Specialize in a single form of medical currency, in a few areas of activity, and in one or two types of molecule.

At SyrHA, we support you on all your healthcare projects in the form of a pre-filled syringe. Our expertise covers the fields of aesthetics, orthopedics, ophthalmics, ophthalmology and dermatology.

We design your hydrogel products in Switzerland and manufacture them in France.

At SyrHA, one molecule reigns supreme: Hyaluronic acid, but our catalog is not limited to it.

Contact us and discover our ready-to-use product portfolio.

Do you have a unique development project? Write to us, we’d love to hear more.  

Explore our environment

  • Company

    They Trust SyrHA : The Excellence of a CDMO

    At SyrHA, we believe that the cornerstone of our success is the unwavering trust that…

    Clients testimonials
  • Company

    Announcing strategic partnership : SyrHA the CDMO and ISHAS organization

    We are pleased to inform you that SyrHA has joined the International Society for Hyaluronic…

  • Company

    CDMO: Evolution of their role

    Innovative biopharmaceutical companies are increasingly engaging in strategic partnerships with CDMOs, whereas in the past,…

    CDMO: Evolution of their role
  • Company

     Join us at IMCAS Paris! 

    We’re delighted to announce that our team will be taking part in the IMCAS 2024…

    IMCAS 2024 World Congress in Paris
  • Company

    SyrHATech is thrilled to install its new autoclave!

    In the field of sterile medical device manufacturing, the terminal sterilization of your products is…

    SyrHATech new autoclave
  • Company

    SyrHATech goes to CPHI Barcelona – from 10/24 to 10/26

    The CPHI (Convention on Pharmaceutical Ingredients) is the reference event for the pharmaceutical industry. Itinerant…

    CPHI Barcelona 2023
  • Company

    Inauguration of Syrhatech’s new premises in Geneva

    The Syrhatech team was delighted to share a convivial moment on its terrace on the…

    Inauguration of Syrhatech's new premises in Geneva
  • Company

    Development of a specific syringe for wrinkle filler

    Our customer contacts us to validate the design of a syringe made of plastic by…

  • Company

    Development of an innovative gel with very high concentration

    Our client contacts us to industrialize a new manufacturing technique, compatible with the objectives of…

  • Company

    Technology transfer

    Our team relies on its many years of experience and past successes, to prepare and…

    Syrhatech - technology transfer